Your trusted source for investing success

Tag: pharmaceuticals

FREE Report - How Will Trump Affect Your Gold Investments? 

Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.

Click here to get your free report!

Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.

 
Founder of Medical Cannabis Council to Join GCAC Australia Board

Founder of Medical Cannabis Council to Join GCAC Australia Board

Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce Adam Miller, founder of the Medical Cannabis Council, will be joining the Board of Directors of Global Cannabis Apps Corporation (Australia) Pty. Ltd. (“GCAC Australia”), the Company’s 61% subsidiary in

Vodis Investor Update

Vodis Investor Update

Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV1)  is pleased to inform investors that it is among the set of applicants to have recently been contacted by Health Canada. The Company’s application to produce cannabis under the ‘Access to Cannabis for Medical Purposes Regulations’ (ACMPR) in Canada is currently in

DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class DNA-targeting Agent, VAL-083

DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class DNA-targeting Agent, VAL-083

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Patent and Trademark Office (USPTO) has issued to DelMar, United States Patent No. 9,759,698 covering improved analytical methods for analyzing and determining impurities in dianhydrogalactitol (VAL-083).

DelMar’s new patent strengthens the Company’s control over

Aeolus Announces Publication of Data

Aeolus Pharmaceuticals shared the publication of a study in a peer-reviewed journal demonstrating that AEOL 10150 improves survival and protects against brain damage and oxidative stress caused by seizures after pilocarpine exposure.

Supreme Completes Sale With Emerald Health Botanicals Inc.

Supreme Completes Sale With Emerald Health Botanicals Inc.

Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc. (“Emerald”), a wholly owned subsidiary of Emerald Health Therapeutics, Inc. (TSXV:EMH).   Emerald is a Canadian Licensed Producer with a focus on

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.

 “The opening of this

InMed Files Provisional Patent

InMed Pharmaceuticals announced the filing of a provisional patent application pertaining to the Company’s proprietary biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Founder of Medical Cannabis Council to Join GCAC Australia Board

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/founder-medical-cannabis-council-join-gcac-australia-board/